Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 11, 2012 - Issue 3
Submit an article Journal homepage
460
Views
14
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Drug safety evaluation of rotigotine

Fabienne Stephanie SprengerMedical University Innsbruck, Department of Neurology, Anichstrasse 35, 6020 Innsbruck, Austria
, MD,
Klaus SeppiMedical University Innsbruck, Department of Neurology, Anichstrasse 35, 6020 Innsbruck, Austria; Medical University Innsbruck, Department of Neurology, Anichstrasse 35, 6020 Innsbruck, Austria+0043 512 504 23850; +0043 512 504 23852; [email protected]
, MD &
Werner PoeweMedical University Innsbruck, Department of Neurology, Anichstrasse 35, 6020 Innsbruck, Austria; Medical University Innsbruck, Department of Neurology, Anichstrasse 35, 6020 Innsbruck, Austria+0043 512 504 23850; +0043 512 504 23852; [email protected]
, MD
Pages 503-512 | Published online: 03 Apr 2012

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Johan Lökk, Sara Olofsson & Ulf Persson. (2014) Willingness to pay for a new drug delivery in Parkinson patients. Journal of Multidisciplinary Healthcare 7, pages 431-440.
Read now
Michele A Faulkner. (2014) Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson’s disease. Expert Opinion on Drug Safety 13:8, pages 1055-1069.
Read now

Articles from other publishers (12)

Rivka Inzelberg & Esther Azizi. 2022. Non-Motor Parkinson's Disease. Non-Motor Parkinson's Disease 187 198 .
Nicki Niemann, Andrew Billnitzer & Joseph Jankovic. (2021) Parkinson's disease and skin. Parkinsonism & Related Disorders 82, pages 61-76.
Crossref
Shadab Md, Shahid Karim, Sanggetha R. Saker, Ooi A. Gie, Lim C. Hooi, Phua H. Yee, Alvin W.C. Kang, Chen K. Zhe, Ng Ian, Hibah M. Aldawsari, Khaled M. Hosny & Nabil A. Alhakamy. (2020) Current Status and Challenges in Rotigotine Delivery. Current Pharmaceutical Design 26:19, pages 2222-2232.
Crossref
Bo Liu, Wenjing Luo, Yingmin Mo, Chunying Wei, Ran Tao & Min Han. (2019) Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease. Neuroscience Letters 707, pages 134313.
Crossref
Martin Klietz, Stephan Greten, Florian Wegner & Günter U. Höglinger. (2019) Safety and Tolerability of Pharmacotherapies for Parkinson’s Disease in Geriatric Patients. Drugs & Aging 36:6, pages 511-530.
Crossref
Saskia Müller-Rebstein, Claudia Trenkwalder, Jens Ebentheuer, Wolfgang H. Oertel, Carsten Culmsee & Günter U. Höglinger. (2017) Drug Safety Analysis in a Real-Life Cohort of Parkinson’s Disease Patients with Polypharmacy. CNS Drugs 31:12, pages 1093-1102.
Crossref
Matej Skorvanek & Kailash P. Bhatia. (2017) The Skin and Parkinson's Disease: Review of Clinical, Diagnostic, and Therapeutic Issues. Movement Disorders Clinical Practice 4:1, pages 21-31.
Crossref
Nadia Raison-Peyron & Bernard Guillot. (2016) Allergic contact dermatitis caused by rotigotine in a transdermal therapeutic system. Contact Dermatitis 75:2, pages 121-122.
Crossref
P. J. Garcia-Ruiz, J. C. Martinez Castrillo, A. Alonso-Canovas, A. Herranz Barcenas, L. Vela, P. Sanchez Alonso, M. Mata, N. Olmedilla Gonzalez & I. Mahillo Fernandez. (2014) Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study. Journal of Neurology, Neurosurgery & Psychiatry 85:8, pages 840-844.
Crossref
Marina Senek & Dag Nyholm. (2013) Continuous Drug Delivery in Parkinson’s Disease. CNS Drugs 28:1, pages 19-27.
Crossref
Liang Ye, Xiaolin Guan, Jingwei Tian, Jianzhao Zhang, Guangying Du, Xin Yu, Pengfei Yu, Xiaobo Cen, Wanhui Liu & Youxin Li. (2013) Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD rats. Food and Chemical Toxicology 56, pages 81-92.
Crossref
Jingwei Tian, Guangying Du, Liang Ye, Xin Yu, Jianzhao Zhang, Hongbo Wang, Pengfei Yu, Fenghua Fu, Wanhui Liu, Youxin Li, Xiaobo Cen & Xiaolin Guan. (2013) Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus monkeys. Food and Chemical Toxicology 52, pages 143-152.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.